Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?

K

Kanuni Sultan Suleyman Training and Research Hospital

Status

Unknown

Conditions

Covid19
Thymic Hypoplasia

Treatments

Diagnostic Test: chest x-ray

Study type

Interventional

Funder types

Other

Identifiers

NCT04470739
KSSEAH--CT

Details and patient eligibility

About

COVID-19 infected pregnant women is thought to have variable degrees of inflammatory response against the disease. Investigators of present study, suggested that fetuses are affected from the possible fetal inflammatory syndrome in case of maternal COVID-19. Therefore the aim of his study is to evaluate that if the cardiothymic index is affected by the maternal COVID-19 and to demonstrate any possible association of this measurement with neonatal morbidities.

Full description

COVID-19 infected pregnant women is thought to have variable degrees of inflammatory response against the disease. Fetus is known to be influenced by maternal systemic infections. Thymus size of fetus and the neonate, is proven to be changed by primarily inflammatory/infectious diseases. Investigators of present study, suggested that fetuses are affected from the possible fetal inflammatory syndrome in case of maternal COVID-19. Therefore the aim of his study is to evaluate that if the cardiothymic index is affected by the maternal COVID-19 and to demonstrate any possible association of this measurement with neonatal morbidities.

Enrollment

20 estimated patients

Sex

All

Ages

Under 7 hours old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Infants born to COVID-19 positive or negative mothers
  • Accepted to participate with an informed consent
  • Infants who required to get chest X-ray within the first 6 hours

Exclusion criteria

  • Infants whose mothers' have any kind of acute or chronic systemic disease or inflammation/infection
  • Lack of an informed consent
  • Infants who did not require to get chest X-ray within the first 6 hours

Trial design

20 participants in 2 patient groups

Infants born to COVID-19 positive mothers
Active Comparator group
Description:
Infants, born to COVID-19 positive mothers, will be evaluated for cardiothymic index in their first chest X-ray.
Treatment:
Diagnostic Test: chest x-ray
Infants born to COVID-19 negative mothers
No Intervention group
Description:
Infants, born to COVID-19 negative mothers, will be evaluated for cardiothymic index in their first chest X-ray.

Trial contacts and locations

0

Loading...

Central trial contact

Seda Yilmaz Semerci

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems